GPR63: A Potential Drug Target Or Biomarker (G81491)

Target Name: GPR63

NCBI ID: G81491

GPR63

GPR63: A Potential Drug Target Or Biomarker

GPR63, also known as brain-expressed G-protein-coupled receptor PSP24 beta, is a protein that is expressed in the brain and is involved in a variety of physiological processes. Despite its importance, little is known about this protein, and it has not yet been fully studied. However, research has shown that GPR63 may be a drug target or biomarker, with potential applications in the development of new treatments for a variety of neurological and psychiatric disorders.

GPR63 is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling. GPCRs are involved in a wide range of processes in the body, including sensory perception, neurotransmitter signaling, and hormone regulation. GPR63 is specifically involved in modulating neurotransmitter release from axonotum muscle fibers, which are responsible for generating force in the muscles.

One of the unique features of GPR63 is its expression in the brain. While GPR63 is not the only GPCR expressed in the brain, it is one of the most well-studied. Studies have shown that GPR63 is highly expressed in the brain and that it is involved in a variety of brain processes, including neurotransmitter release, synaptic plasticity, and stress response.

In addition to its role in brain processes, GPR63 has also been shown to be involved in a variety of diseases and disorders. For example, GPR63 has been linked to a number of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. Additionally, GPR63 has been shown to be involved in the development of neurodegenerative diseases, such as ALS and Huntington's disease.

GPR63's potential as a drug target or biomarker comes from its involvement in a variety of brain processes and its involvement in a number of disorders. While further research is needed to fully understand the role of GPR63 in these processes, its potential as a drug target or biomarker is an exciting area of research with the potential to lead to new treatments for a variety of neurological and psychiatric disorders.

In conclusion, GPR63 is a protein that is expressed in the brain and is involved in a variety of physiological processes. While further research is needed to fully understand its role, its potential as a drug target or biomarker is an exciting area of research with the potential to lead to new treatments for a variety of neurological and psychiatric disorders.

Protein Name: G Protein-coupled Receptor 63

Functions: Orphan receptor. May play a role in brain function

The "GPR63 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR63 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets